Kontron Transportation has announced a service contract with Société Nationale des Chemins de fer Français (SNCF), representing the continuation of a longstanding partnership between Kontron ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales ...

Ryoncil ® is the first and only FDA approved mesenchymal stromal cell (MSC) product in the Unites States and became commercially available for purchase on March 28, 2025, within one quarter of ...